News Title |
|
|
|
|
 |
Chapter |
Change |
Reason for change |
04.09.03 |
Riluzole. Amend RAG rating to RED for South Tyneside, Sunderland, North of Tyne, Gateshead and North Cumbria; AMBER for County Durham and Tees and linked to Shared Care Guidance |
Formulary merger |
02.02.03 |
Finerenone. Moved from chapter 06.01.05 to 02.02.03 |
Formulary merger |
12.03.05 |
Oralieve®. Addition of Oralieve® Moisturising spray and gel to artifical saliva (GREEN) |
Formulary merger |
11.05 |
Mydricaine® No 2. Added to the formulary (RED) |
Formulary merger |
13.06.01 |
Adapalene & benzoyl peroxide. Addition of 0.3%/2.5% strength (GREEN) |
Formulary merger |
13.05.02 |
Calcipotriol & betamethasone. Addition of cream (Wynzora®) (GREEN) |
Formulary merger |
04.10.02 |
Bupropion. Addition of resistant depression as an approved indiction (RED) |
Formulary merger |
09.05.03 |
Sodium fluoride. Addition of NHSE guidance for over the counter items not routinely prescribed in primary care |
Formulary merger |
09.01.03 |
Roxadustat. Added to the formulary (RED) |
NICE TA807 |
06.07.02 |
Relugolix–estradiol–norethisterone acetate. RAG rating changed from RED to GREEN PLUS |
Formulary merger |
09.01.04 |
Avatrombopag. Approved indication added for the treatment of primary chronic immune thrombocytopenia (RED) |
NICE TA853 |
04.06 |
Cinnarzine – removal of duplicate entry |
Formulary merger |
04.07.03 |
Gabapentin. Addition of approved indication for the treatment of intractabel itch with severe burns (GREEN PLUS) |
Formulary merger |
05.04.01 |
Dihydroartemisinin/piperaquinephosphate. Added to the formulary (RED) |
Formulary merger |
01.10 |
Botulinum A toxin. Addition of approved indication for the repair of complex hernia (RED) |
Formulary merger |
11.04.02 |
Ciclosporin 1mg/mL (0.1%) eye drops. Addition of Verkazia® for the treatment of severe vernal keratoconjunctivitis in children from 4 years of age and adolescents (GREEN PLUS) |
Formulary merger |
09.02.01.01 |
Patiromer. Amended RAG rating for hyperkalaemia (GREEN PLUS) and acute treatment (RED) |
Formulary merger |
09.02.01.01 |
Sodium zirconium. Amended RAG rating for hyperkalaemia (GREEN PLUS) and acute treatment (RED) |
Formulary merger |
02.02.01 |
Chlorothiazide. Amended wording to include nephrology specialty |
Formulary merger |
21/07/2023 |
|
|
|
|
|